Back

Impact of CHA2DS2-VASc score on smartphone-based screening for atrial fibrillation: A pre-specified subgroup analysis of the eBRAVE-AF trial

25 August 2023 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Risks and screening for atrial fibrillation Photoplethysmography ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Luisa Freyer

Ludwig Maximilians University, Munich (Germany)

6 More presentations in this session

Presentation thumbnail
Factors for incorrect automated atrial fibrillation identification in large-scale screening
Doctor M. Zink (Aachen, DE)
Abstract Slides Video
Presentation thumbnail
Diagnostic accuracy of handheld single-lead electrocardiographic devices to detect atrial fibrillation: an examination using more than 30,000 rhythm traces in a randomised control trial.
Doctor K. Wong (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
A polygenic risk score predicts atrial fibrillation in patients with coronary artery disease without severe systolic dysfunction.
Doctor R. Sandhu (Calgary, CA)
Abstract Slides Video
Presentation thumbnail
The significance of excessive supraventricular ectopic activity immediately after catheter ablation in the risk stratification for late recurrence of atrial fibrillation
Doctor T. Fujisawa (Toon, JP)
Abstract Slides Video
Presentation thumbnail
Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy
Doctor T. Sakthivel (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Risks and screening for atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August 2023 10:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources